Pericardial mesothelioma is a rare form of cancer that affects the pericardium, which is the thin membrane surrounding the heart. Like other types of mesothelioma, pericardial mesothelioma is primarily caused by exposure to asbestos fibers. However, it is even rarer than other types of mesothelioma, accounting for only a small percentage of all mesothelioma cases.
Exposure to asbestos can occur through inhalation or ingestion of asbestos fibers, with the fibers becoming lodged in the lining of the pericardium over time. These fibers can cause inflammation, scarring, and ultimately lead to the development of cancerous cells.
Symptoms of pericardial mesothelioma can include:
- Chest pain
- Difficulty breathing
- Irregular heartbeat (arrhythmia)
- Persistent cough
- Fatigue
- Fever
- Night sweats
- Swelling of the face and arms
Diagnosing pericardial mesothelioma often involves a combination of imaging tests such as CT scans, MRIs, and echocardiograms, as well as a biopsy to confirm the presence of mesothelioma cells.
Treatment options for pericardial mesothelioma may include surgery, chemotherapy, radiation therapy, and/or immunotherapy, depending on the stage of the cancer and the overall health of the patient. Due to its rarity and the challenges associated with early detection, pericardial mesothelioma typically carries a poor prognosis. However, advancements in treatment approaches and therapies offer hope for improved outcomes and quality of life for patients diagnosed with this condition.
